{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:37:41Z","timestamp":1787164661823,"version":"build-2736575974"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:00:00Z","timestamp":1590710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1007\/s10067-020-05179-0","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T00:08:02Z","timestamp":1590710882000},"page":"2077-2084","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Treatment algorithm for COVID-19: a multidisciplinary point of view"],"prefix":"10.1007","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7485-471X","authenticated-orcid":false,"given":"Felice","family":"Galluccio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolga","family":"Ergonenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Garcia Martos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdallah El-Sayed","family":"Allam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"P\u00e9rez-Herrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Aguilar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Emmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Spinicci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Terrancle Juan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Fajardo-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"5179_CR1","doi-asserted-by":"publisher","unstructured":"Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis; published online Feb 19. https:\/\/doi.org\/10.1016\/S1473-3099(20)30120-1","DOI":"10.1016\/S1473-3099(20)30120-1"},{"key":"5179_CR2","doi-asserted-by":"publisher","unstructured":"Han Q, Lin Q, Ni Z, You L (2020) Uncertainties about the transmission routes of 2019 novel coronavirus. Infuenza Other Respir Viruses. https:\/\/doi.org\/10.1111\/irv.12735","DOI":"10.1111\/irv.12735"},{"key":"5179_CR3","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1038\/s41575-020-0295-7","volume":"17","author":"J Hindson","year":"2020","unstructured":"Hindson J (2020) COVID-19: faecal-oral transmission? Nat Rev Gastroenterol Hepatol 17:259. https:\/\/doi.org\/10.1038\/s41575-020-0295-7","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"5179_CR4","doi-asserted-by":"crossref","unstructured":"Bai Y, Yao L, Wei T et al (2020) Presumed asymptomatic carrier transmission of COVID-19 [published online ahead of print, 2020. JAMA.:e202565","DOI":"10.1001\/jama.2020.2565"},{"key":"5179_CR5","doi-asserted-by":"crossref","unstructured":"Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J et al (2020) Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel coronavirus-infected pneumonia in Wuhan, China. JAMA","DOI":"10.1001\/jama.2020.1585"},{"key":"5179_CR6","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1056\/NEJMoa2002032","volume":"382","author":"WJ Guan","year":"2020","unstructured":"Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, Liu L, Shan H, Lei CL, Hui DSC, du B, Li LJ, Zeng G, Yuen KY, Chen RC, Tang CL, Wang T, Chen PY, Xiang J, Li SY, Wang JL, Liang ZJ, Peng YX, Wei L, Liu Y, Hu YH, Peng P, Wang JM, Liu JY, Chen Z, Li G, Zheng ZJ, Qiu SQ, Luo J, Ye CJ, Zhu SY, Zhong NS, China Medical Treatment Expert Group for Covid-19 (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382:1708\u20131720. https:\/\/doi.org\/10.1056\/NEJMoa2002032","journal-title":"N Engl J Med"},{"key":"5179_CR7","unstructured":"Lei C, Huigo L, Wei L, Jing L, Kui L, Jin S et al (2020) Analysis of clinical features of 29 patients with 2019 novel coronavirus pneumonia. Chin J Tuberc Respir Dis"},{"issue":"10229","key":"5179_CR8","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"P Mehta","year":"2020","unstructured":"Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet 395(10229):1033\u20131034. https:\/\/doi.org\/10.1016\/S0140-6736(20)30628-0","journal-title":"Lancet"},{"key":"5179_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1097\/CM9.0000000000000744","volume":"133","author":"L Kui","year":"2020","unstructured":"Kui L, Fang YY, Deng Y, Liu W, Wang MF, Ma JP et al (2020) Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province. Chin Med J 133:1025\u20131031. https:\/\/doi.org\/10.1097\/CM9.0000000000000744","journal-title":"Chin Med J"},{"key":"5179_CR10","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","volume":"395","author":"N Chen","year":"2020","unstructured":"Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, Qiu Y, Wang J, Liu Y, Wei Y, Xia J', Yu T, Zhang X, Zhang L (2020) Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 395:507\u2013513","journal-title":"Lancet."},{"issue":"10223","key":"5179_CR11","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","volume":"395","author":"C Huang","year":"2020","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B (2020) Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 395(10223):497\u2013506","journal-title":"Lancet"},{"key":"5179_CR12","doi-asserted-by":"publisher","unstructured":"Pan F, Ye T, Sun P, Gui S, Liang B, Li L, Zheng D, Wang J, Hesketh RL, Yang L, Zheng C (2020) Time course of lung changes on chest CT during recovery from 2019 novel coronavirus (COVID-19) pneumonia. Radiology. https:\/\/doi.org\/10.1148\/radiol.2020200370","DOI":"10.1148\/radiol.2020200370"},{"key":"5179_CR13","doi-asserted-by":"publisher","unstructured":"Wong HYF, Lam HYS, Fong AH, Leung ST, Chin TW, Lo CSY, Lui MM, Lee JCY, Chiu KW, Chung T, Lee EYP, Wan EYF, Hung FNI, Lam TPW, Kuo M, Ng MY (2019) Frequency and distribution of chest radiographic findings in COVID-19 positive patients. Radiology. https:\/\/doi.org\/10.1148\/radiol.2020201160","DOI":"10.1148\/radiol.2020201160"},{"key":"5179_CR14","doi-asserted-by":"publisher","unstructured":"Peng Q-Y, Wang X-T, Zhang L-N (2020) Findings of lung ultrasonography of novel corona virus pneumonia during the 2019\u20132020 epidemic. Intensive Care Medic. https:\/\/doi.org\/10.1007\/s00134-020-05996-6","DOI":"10.1007\/s00134-020-05996-6"},{"key":"5179_CR15","doi-asserted-by":"publisher","unstructured":"Soldati G, Smargiassi A, Inchingolo R, Buonsenso D, Perrone T, Briganti DF, Perlini S, Torri E, Mariani A, Mossolani EE, Tursi F, Mento F, Demi L (2020) Is there a role for lung ultrasound during the COVID-19 pandemic? J Ultrasound Med. https:\/\/doi.org\/10.1002\/jum.15284","DOI":"10.1002\/jum.15284"},{"key":"5179_CR16","unstructured":"Chan C, Lai S, Chu C, Tsui C, Tam M, Wong M et al Treatment of severe acute respiratory syndrome with lopinavir\/ritonavir: a multicentre retrospective matched cohort study. Hong Kong Med J 9"},{"key":"5179_CR17","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","volume":"382","author":"B Cao","year":"2020","unstructured":"Cao B, Wang Y, Wen D, Liu W, Wang J, Fan G, Ruan L, Song B, Cai Y, Wei M, Li X, Xia J, Chen N, Xiang J, Yu T, Bai T, Xie X, Zhang L, Li C, Yuan Y, Chen H, Li H, Huang H, Tu S, Gong F, Liu Y, Wei Y, Dong C, Zhou F, Gu X, Xu J, Liu Z, Zhang Y, Li H, Shang L, Wang K, Li K, Zhou X, Dong X, Qu Z, Lu S, Hu X, Ruan S, Luo S, Wu J, Peng L, Cheng F, Pan L, Zou J, Jia C, Wang J, Liu X, Wang S, Wu X, Ge Q, He J, Zhan H, Qiu F, Guo L, Huang C, Jaki T, Hayden FG, Horby PW, Zhang D, Wang C (2020) A trial of lopinavir-ritonavir in adults hospitalized with severe Covid-19. N Engl J Med 382:1787\u20131799. https:\/\/doi.org\/10.1056\/NEJMoa2001282","journal-title":"N Engl J Med"},{"key":"5179_CR18","doi-asserted-by":"publisher","unstructured":"Wang M, Cao R, Zhang L, Yang X, Liu J, Xu M et al (2020) Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res. https:\/\/doi.org\/10.1038\/s41422-020-0282-0","DOI":"10.1038\/s41422-020-0282-0"},{"issue":"6485","key":"5179_CR19","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1126\/science.367.6485.1412","volume":"367","author":"K Kupferschmidt","year":"2020","unstructured":"Kupferschmidt K, Cohen J (2020) Race to find COVID-19 treatments accelerates. Science. 367(6485):1412\u20131413. https:\/\/doi.org\/10.1126\/science.367.6485.1412","journal-title":"Science."},{"issue":"3","key":"5179_CR20","doi-asserted-by":"publisher","first-page":"105924","DOI":"10.1016\/j.ijantimicag.2020.105924","volume":"55","author":"L Chih-Cheng","year":"2020","unstructured":"Chih-Cheng L, Tzu-Ping S, Wen-Chien K, Hung-Jen T, Po-Ren H (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): the epidemic and the challenges. Int J Antimicrob Agents 55(3):105924. https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105924","journal-title":"Int J Antimicrob Agents"},{"key":"5179_CR21","unstructured":"(2020) Multicenter collaboration group of Department of Science and Technology of Guangdong Province and Health Commission of Guangdong Province for chloroquine in the treatment of novel coronavirus pneumonia. [Expert consensus on chloroquine phosphate for the treatment of novel coronavirus pneumonia]. Zhonghua Jie He He Hu Xi Za Zhi 43:E019"},{"issue":"1","key":"5179_CR22","doi-asserted-by":"publisher","first-page":"8543","DOI":"10.4081\/idr.2020.8543","volume":"12","author":"E Nicastri","year":"2020","unstructured":"Nicastri E, Petrosillo N, Bartoli TA et al (2020) National Institute for the Infectious Diseases \u201cL. Spallanzani\u201d, IRCCS. Recommendations for COVID-19 clinical management. Infect Dis Rep 12(1):8543. Published 2020 Mar 16. https:\/\/doi.org\/10.4081\/idr.2020.8543","journal-title":"Infect Dis Rep"},{"key":"5179_CR23","doi-asserted-by":"crossref","unstructured":"Yao X, Ye F, Zhang M et al (2020) In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Clin Infect Dis","DOI":"10.1093\/cid\/ciaa237"},{"key":"5179_CR24","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1186\/1743-422X-2-69","volume":"2","author":"MJ Vincent","year":"2005","unstructured":"Vincent MJ, Bergeron E, Benjannet S, Erickson BR, Rollin PE, Ksiazek TG, Seidah NG, Nichol ST (2005) Chloroquine is a potent inhibitor of SARS coronavirus infection and spread. Virol J 2:69","journal-title":"Virol J"},{"issue":"3","key":"5179_CR25","doi-asserted-by":"publisher","DOI":"10.3171\/2014.12.FOCUS14748","volume":"38","author":"EB Golden","year":"2015","unstructured":"Golden EB, Cho HY, Hofman FM, Louie SG, Schonthal AH, Chen TC (2015) Quinoline-based antimalarial drugs: a novel class of autophagy inhibitors. Neurosurg Focus 38(3):E12","journal-title":"Neurosurg Focus"},{"key":"5179_CR26","doi-asserted-by":"publisher","unstructured":"Gao J, Tian Z, Yang X (2020) Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. https:\/\/doi.org\/10.5582\/bst.2020.01047","DOI":"10.5582\/bst.2020.01047"},{"key":"5179_CR27","doi-asserted-by":"publisher","unstructured":"Chen Z Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial. MedRxiv preprint. https:\/\/doi.org\/10.1101\/2020.03.22.20040","DOI":"10.1101\/2020.03.22.20040"},{"key":"5179_CR28","doi-asserted-by":"publisher","unstructured":"Gautret et al. (2020) Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial. Int J Antimicrob Agents (In Press 17 March 2020). https:\/\/doi.org\/10.1016\/j.ijantimicag.2020.105949","DOI":"10.1016\/j.ijantimicag.2020.105949"},{"key":"5179_CR29","doi-asserted-by":"publisher","unstructured":"Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM The FDA approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antivir Res. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104787","DOI":"10.1016\/j.antiviral.2020.104787"},{"issue":"4","key":"5179_CR30","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1093\/cid\/civ334","volume":"61","author":"CS Kraft","year":"2015","unstructured":"Kraft CS, Hewlett AL, Koepsell S et al (2015) Nebraska biocontainment unit and the emory serious communicable diseases unit. The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States. Clin Infect Dis 61(4):496\u2013502","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5179_CR31","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1056\/NEJMoa1511812","volume":"374","author":"J van Griensven","year":"2016","unstructured":"van Griensven J, Edwards T, de Lamballerie X et al (2016) Ebola-Tx Consortium. Evaluation of convalescent plasma for Ebola virus disease in Guinea. N Engl J Med 374(1):33\u201342","journal-title":"N Engl J Med"},{"issue":"14","key":"5179_CR32","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMc070359","volume":"357","author":"B Zhou","year":"2007","unstructured":"Zhou B, Zhong N, Guan Y (2007) Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 357(14):1450\u20131451","journal-title":"N Engl J Med"},{"issue":"4","key":"5179_CR33","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1093\/cid\/ciq106","volume":"52","author":"IF Hung","year":"2011","unstructured":"Hung IF, To KK, Lee CK et al (2011) Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clin Infect Dis 52(4):447\u2013456","journal-title":"Clin Infect Dis"},{"issue":"4","key":"5179_CR34","first-page":"309","volume":"9","author":"T Burnouf","year":"2003","unstructured":"Burnouf T, Radosevich M (2003) Treatment of severe acute respiratory syndrome with convalescent plasma. Hong Kong Med J. 9(4):309","journal-title":"Hong Kong Med J."},{"issue":"1","key":"5179_CR35","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13054-020-2818-6","volume":"24","author":"AC Cunningham","year":"2020","unstructured":"Cunningham AC, Goh HP, Koh D (2020) Treatment of COVID-19: old tricks for new challenges. Crit Care 24(1):91. Published 2020 Mar 16. https:\/\/doi.org\/10.1186\/s13054-020-2818-6","journal-title":"Crit Care"},{"key":"5179_CR36","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/s1473-3099(20)30141-9","volume":"20","author":"L Chen","year":"2020","unstructured":"Chen L, Xiong J, Bao L, Shi Y (2020) Convalescent plasma as a potential therapy for COVID-19. Lancet Infect Dis 20:398\u2013400. https:\/\/doi.org\/10.1016\/s1473-3099(20)30141-9","journal-title":"Lancet Infect Dis"},{"key":"5179_CR37","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jama.2020.4783","volume":"323","author":"C Shen","year":"2020","unstructured":"Shen C, Wang Z, Zhao F, Yang Y, Li J, Yuan J, Wang F, Li D, Yang M, Xing L, Wei J, Xiao H, Yang Y, Qu J, Qing L, Chen L, Xu Z, Peng L, Li Y, Zheng H, Chen F, Huang K, Jiang Y, Liu D, Zhang Z, Liu Y, Liu L (2020) Treatment of 5 critically ill patients with COVID-19 with convalescent plasma. JAMA. 323:1582. https:\/\/doi.org\/10.1001\/jama.2020.4783","journal-title":"JAMA."},{"key":"5179_CR38","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1111\/jth.14781","volume":"18","author":"D Lillicrap","year":"2020","unstructured":"Lillicrap D (2020) Disseminated intravascular coagulation in patients with 2019-nCoV pneumonia. J Thromb Haemost 18:786\u2013787. https:\/\/doi.org\/10.1111\/jth.14781","journal-title":"J Thromb Haemost"},{"key":"5179_CR39","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1111\/jth.14768","volume":"18","author":"N Tang","year":"2020","unstructured":"Tang N, Li D, Wang X, Sun Z (2020) Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 18:844\u2013847. https:\/\/doi.org\/10.1111\/jth.14768","journal-title":"J Thromb Haemost"},{"issue":"1","key":"5179_CR40","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","volume":"9","author":"L Lin","year":"2020","unstructured":"Lin L, Lu L, Cao W, Li T (2020) Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect 9(1):727\u2013732","journal-title":"Emerg Microbes Infect"},{"key":"5179_CR41","doi-asserted-by":"publisher","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J (2020; published online March 3.) Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. https:\/\/doi.org\/10.1007\/s00134-020-05991-x","DOI":"10.1007\/s00134-020-05991-x"},{"key":"5179_CR42","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/S0140-6736(13)61048-X","volume":"383","author":"M Ramos-Casals","year":"2014","unstructured":"Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, Khamashta MA, Bosch X (2014) Adult haemophagocytic syndrome. Lancet 383:1503\u20131516","journal-title":"Lancet"},{"key":"5179_CR43","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fimmu.2019.00055","volume":"10","author":"E Karakike","year":"2019","unstructured":"Karakike E, Giamarellos-Bourboulis EJ (2019) Macrophage activation-like syndrome: a distinct entity leading to early death in sepsis. Front Immunol 10:55","journal-title":"Front Immunol"},{"key":"5179_CR44","doi-asserted-by":"publisher","unstructured":"Yang X, Yu Y, Xu J et al (2020; Published Online February 21.) Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. https:\/\/doi.org\/10.1016\/S2213-2600(20)30079-5","DOI":"10.1016\/S2213-2600(20)30079-5"},{"key":"5179_CR45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.blre.2018.11.002","volume":"34","author":"JN Brudno","year":"2019","unstructured":"Brudno JN, Kochenderfer JN (2019) Recent advances in CAR T-cell toxicity: mechanisms, manifestations and management. Blood Rev 34:45\u201355. https:\/\/doi.org\/10.1016\/j.blre.2018.11.002","journal-title":"Blood Rev"},{"key":"5179_CR46","unstructured":"Xu X, Han M, Li T et al Effective treatment of severe COVID-19 patients with tocilizumab. chinaXiv 202003.00026v1"},{"key":"5179_CR47","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/CCM.0000000000001402","volume":"44","author":"B Shakoory","year":"2016","unstructured":"Shakoory B, Carcillo JA, Chatham WW, Amdur RL, Zhao H, Dinarello CA, Cron RQ, Opal SM (2016) Interleukin-1 receptor blockade is associated with reduced mortality in sepsis patients with features of macrophage activation syndrome: reanalysis of a prior phase iii trial. Crit Care Med 44:275\u2013281","journal-title":"Crit Care Med"},{"key":"5179_CR48","doi-asserted-by":"crossref","unstructured":"Eloseily EM, Weiser P, Crayne CB, Haines H, Mannion ML, Stoll ML et al (2019) Benefit of anakinra in treating pediatric secondary hemophagocytic lymphohistiocytosis. Arthritis Rheumatol","DOI":"10.1002\/art.41103"},{"key":"5179_CR49","doi-asserted-by":"publisher","unstructured":"Stebbing J, Phelan A, Griffin I, Tucker C, Oechsle O, Smith D, Richardson P (2020) COVID-19: combining antiviral and anti-inflammatory treatments. Lancet Infect Dis. https:\/\/doi.org\/10.1016\/S1473-3099(20)30132-8","DOI":"10.1016\/S1473-3099(20)30132-8"},{"issue":"10223","key":"5179_CR50","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/S0140-6736(20)30304-4","volume":"395","author":"P Richardson","year":"2020","unstructured":"Richardson P, Griffin I, Tucker C, Smith D, Oechsle O, Phelan A, Stebbing J (2020) Baricitinib as potential treatment for 2019-nCoV acute respiratory disease. Lancet. 395(10223):e30\u2013e31. https:\/\/doi.org\/10.1016\/S0140-6736(20)30304-4","journal-title":"Lancet."},{"issue":"23","key":"5179_CR51","doi-asserted-by":"publisher","first-page":"4131","DOI":"10.1182\/bloodadvances.2019000898","volume":"3","author":"SR Goldsmith","year":"2019","unstructured":"Goldsmith SR, Saif Ur Rehman S, Shirai CL, Vij K, DiPersio JF (2019) Resolution of secondary hemophagocytic lymphohistiocytosis after treatment with the JAK1\/2 inhibitor ruxolitinib. Blood Adv 3(23):4131\u20134135. https:\/\/doi.org\/10.1182\/bloodadvances.2019000898","journal-title":"Blood Adv"},{"key":"5179_CR52","doi-asserted-by":"publisher","unstructured":"Qu R, Ling Y, Zhang Y-h-z et al (2020) Platelet-to-lymphocyte ratio is associated with prognosis in patients with coronavirus disease-19. J Med Virol:1\u20139. https:\/\/doi.org\/10.1002\/jmv.25767","DOI":"10.1002\/jmv.25767"},{"key":"5179_CR53","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1016\/S0140-6736(20)30317-2","volume":"395","author":"CD Russell","year":"2020","unstructured":"Russell CD, Millar JE, Baillie JK (2020) Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury. Lancet 395:473\u2013475","journal-title":"Lancet"},{"issue":"10225","key":"5179_CR54","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/S0140-6736(20)30361-5","volume":"395","author":"L Shang","year":"2020","unstructured":"Shang L, Zhao J, Hu Y, Du R, Cao B (2020) On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 395(10225):683\u2013684. https:\/\/doi.org\/10.1016\/S0140-6736(20)30361-5","journal-title":"Lancet."},{"key":"5179_CR55","doi-asserted-by":"publisher","unstructured":"Inciardi RM, Lupi L, Zaccone G et al (2020) Cardiac involvement in a patient with coronavirus disease 2019 (COVID-19). [published online ahead of print]., JAMA Cardiol. https:\/\/doi.org\/10.1001\/jamacardio.2020.1096","DOI":"10.1001\/jamacardio.2020.1096"},{"issue":"5","key":"5179_CR56","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1097\/PCC.0000000000000098","volume":"15","author":"DW Simon","year":"2014","unstructured":"Simon DW, Aneja R, Carcillo JA, Halstead ES (2014) Plasma exchange, methylprednisolone, IV immune globulin, and now anakinra support continued PICU equipoise in management of hyperferritinemia-associated sepsis\/multiple organ dysfunction syndrome\/macrophage activation syndrome\/secondary hemophagocytic lymphohistiocytosis syndrome*. Pediatr Crit Care Med 15(5):486\u2013488. https:\/\/doi.org\/10.1097\/PCC.0000000000000098","journal-title":"Pediatr Crit Care Med"},{"issue":"25","key":"5179_CR57","doi-asserted-by":"publisher","first-page":"2728","DOI":"10.1182\/blood-2017-06-788349","volume":"130","author":"E Bergsten","year":"2017","unstructured":"Bergsten E, Horne A, Aric\u00f3 M, Astigarraga I, Egeler RM, Filipovich AH, Ishii E, Janka G, Ladisch S, Lehmberg K, McClain KL, Minkov M, Montgomery S, Nanduri V, Rosso D, Henter JI (2017) Confirmed efficacy of etoposide and dexamethasone in HLH treatment: long-term results of the cooperative HLH-2004 study. Blood. 130(25):2728\u20132738. https:\/\/doi.org\/10.1182\/blood-2017-06-788349","journal-title":"Blood."},{"issue":"21","key":"5179_CR58","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1182\/blood.2019002289","volume":"134","author":"M Vallurupalli","year":"2019","unstructured":"Vallurupalli M, Berliner N (2019) Emapalumab for the treatment of relapsed\/refractory hemophagocytic lymphohistiocytosis. Blood. 134(21):1783\u20131786. https:\/\/doi.org\/10.1182\/blood.2019002289","journal-title":"Blood."}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-020-05179-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-020-05179-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,28]],"date-time":"2021-05-28T20:21:48Z","timestamp":1622233308000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-020-05179-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["5179"],"URL":"https:\/\/doi.org\/10.1007\/s10067-020-05179-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]},"assertion":[{"value":"5 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}